Searched for
IQVIA MAT
Lupin shares in focus after FDA nod for post-eye surgery drug Loteprednol Etabonate GelShares of Lupin are set to be in focus after it received US FDA approval for its generic Loteprednol Etabonate Ophthalmic Gel, granting it ...- Zydus gets USFDA nod for generic IBS-D treatment drugZydus Lifesciences has secured tentative approval from the USFDA to market Rifaximin Tablets (550 mg) in the United States. This medication...
- JB Pharma Q3 net profit jumps 22% to Rs 162 croreJB Pharma on Tuesday reported a 22% year-on-year (Y-o-Y) jump in net profit to Rs 162 crore for the quarter ended December 31 led by strong...
- Zydus Lifesciences gets USFDA nod for asthma treatment drugZydus Lifesciences Ltd receives final USFDA approval to market generic Theophylline extended-release tablets of strengths 300 mg and 450 mg...
- Zydus Lifesciences gets USFDA approval for generic acne treatment gelZydus Lifesciences Ltd received final approval from the US Food and Drug Administration (USFDA) to market its generic version of Dapsone ge...
- Lupin gets USFDA nod to market generic drug for treatment of lung diseaseLupin on Friday said it has received approval from US FDA to market a generic product, used in the treatment of a lung disease, in the Amer...
- Pharma growth shrinks to 4.5% in June as Covid-led segments show decrease in salesIndia's pharmaceutical market contracted by 4.5% in June due to a fall in anti-infectives and respiratory drug sales as Covid cases decreas...
- Lupin gets tentative USFDA approval to market generic valbenazine capsulesThese are the generic equivalent of Ingrezza capsules, 40 mg, 60 mg, and 80 mg, of Neurocrine Biosciences, Inc, it added. Valbenazine capsu...
- Lupin launches generic medication in US marketDrug firm Lupin on Tuesday said it has launched a generic anti-psychotic medication in the US market. The company's product, in strengths o...
- Lupin launches generic joint pain drug in US marketThe company's product -- Diclofenac Sodium Topical Solution 2 per cent -- is the generic version of Horizon Pharma Therapeutics Pennsaid, L...
- Lupin gets USFDA nod for generic oral contraceptive pillLupin has received tentative approval from the US Food and Drug Administration (FDA) for its abbreviated new drug application (ANDA), Drosp...
- Zydus Lifesciences gets USFDA nod for 2 generic drugsThe tentative approval granted by the US Food and Drug Administration (USFDA) to the company's arm Zydus Worldwide DMCC to market Valbenazi...
- Lupin gets USFDA nod for generic cancer treatment drugLupin in partnership with Pharmascience Inc. has received approval from the US Food and Drug Administration (FDA) for Dasatinib tablets in ...
- Lupin launches generic contraceptive drug in USDrug maker Lupin On Thursday said it has launched Merzee capsules, a medication used to prevent pregnancy, in the US market. The Mumbai-bas...
- Lupin launches generic medication in US marketLupin has launched Sevelamer Hydrochloride tablets (800 mg), used to treat hyperphosphatemia in patients with chronic kidney disease, in th...
- Lupin gets USFDA nod for generic productAs per IQVIA MAT September 2021 data, Sevelamer Carbonate for Oral Suspension had estimated annual sales of USD 51.7 million in the US.
- Lupin launches generic antifungal product in US marketTavaborole Topical Solution is generic equivalent of Anacor Pharmaceuticals' Kerydin Topical Solution and is an oxaborole antifungal indica...
- Lupin launches generic drug in the US marketThe Mumbai-based drug firm's product is the generic equivalent of Zyla Life Sciences' Vivlodex Capsules (5 mg and 10 mg). The capsules are ...
- Lupin gets USFDA nod for Asthma drugQuoting IQVIA MAT September data, Lupin said, the said Asthma drug had annual sales of around USD 474.5 million in the US.
- Lupin launches plaque psoriasis treatment spray in US marketQuoting IQVIA MAT May 2018 data, Lupin said Desoximetasone Topical Spray, 0.25 per cent, had annual sales of approximately USD 18.7 million...
Load More
